as well extensive networks, in all phases of the drug development process from discovery through commercialization.

Their objective is to accelerate and enhance value for their portfolio companies by bridging the management and financial gap between innovators and the marketplace, as well as achieve key early stage milestones in the product development process. Apjohn Group is well connected with local and national angel investors and venture capital firms interested specifically in life sciences. The Apjohn Group LLC is an advisor to (Apjohn Ventures Fund); the two general partners help found both firms.